Press Releases
April 16 2013
September 9 2011
June 29 2011
April 19 2011
June 26 2007
Key Documents
Letters, Testimony & Comments
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
May 25 2011
Representatives of the bioscience industry testified before the U.S. Congress Joint Economic Committee today, as part of a hearing entitled Driving Innovation and Job Growth through the Life Sciences Industry.
April 1 2011
BIO submitted comments in response to the Request for Comments on the Strategy for American Innovation issued by the U.S. Department of Commerce. BIO addressed policies relating to government research and development, entrepreneurship, intellectual property, and incentives to innovate. BIO encouraged the Department of Commerce to help create an environment conducive to risk-taking and one that will unleash the tremendous potential of biotechnology.
January 11 2011
BIO and 23 other renewable energy groups have joined together in a letter to the White House requesting full funding and support of the Department of Agriculture's renewable energy program in the President's Budget for fiscal year 2012.
May 27 2010
The paper highlights factors that contribute to enabling environments for promising technologies to gain access to early capital.
Want to learn more about the biotech industry?
Business Solutions Sponsor
